Cited by 802Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disorders

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

Open access

Rawshani, Araz, Sattar, Naveed, Franzén, Stefan, Rawshani, Aidin, Hattersley, Andrew T, Svensson, Ann-Marie, Eliasson, Björn, Gudbjörnsdottir, Soffia·2018·The Lancet

DOI 10.1016/s0140-6736(18)31506-xPMC PMC6828554

Open this paper in CoChat — free account Open PDF

Abstract

Background People with type 1 diabetes are at elevated risk of mortality and cardiovascular disease, yet current guidelines do not consider age of onset as an important risk stratifier. We aimed to examine how age at diagnosis of type 1 diabetes relates to excess mortality and cardiovascular risk.Methods We did a nationwide, register-based cohort study of individuals with type 1 diabetes in the Swedish National Diabetes Register and matched controls from the general population. We included patients with at least one registration between Jan 1, 1998, and Dec 31, 2012. Using Cox regression, and with adjustment for diabetes duration, we estimated the excess risk of all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, acute myocardial infarction, stroke, cardiovascular disease (a composite of acute myocardial infarction and stroke), coronary heart disease, heart failure, and atrial fibrillation. Individuals with type 1 diabetes were categorised into five groups, according to age at diagnosis: 0-10 years, 11-15 years, 16-20 years, 21-25 years, and 26-30 years.Findings 27 195 individuals with type 1 diabetes and 135 178 matched controls were selected for this study. 959 individuals with type 1 diabetes and 1501 controls died during follow-up (median follow-up was 10 years). Patients who developed type 1 diabetes at 0-10 years of age had hazard ratios of 4·11 (95% CI 3·24-5·22) for all-cause mortality, 7·38 (3·65-14·94) for cardiovascular mortality, 3·96 (3·06-5·11) for non-cardiovascular mortality, 11·44 (7·95-16·44) for cardiovascular disease, 30·50 (19·98-46·57) for coronary heart disease, 30·95 (17·59-54·45) for acute myocardial infarction, 6·45 (4·04-10·31) for stroke, 12·90 (7·39-22·51) for heart failure, and 1·17 (0·62-2·20) for atrial fibrillation. Corresponding hazard ratios for individuals who developed type 1 diabetes aged 26-30 years were 2·83 (95% CI 2·38-3·37) for all-cause mortality, 3·64 (2·34-5·66) for cardiovascular mortality, 2·78 (2·29-3·38) for non-cardiovascular mortality, 3·85 (3·05-4·87) for cardiovascular disease, 6·08 (4·71-7·84) for coronary heart disease, 5·77 (4·08-8·16) for acute myocardial infarction, 3·22 (2·35-4·42) for stroke, 5·07 (3·55-7·22) for heart failure, and 1·18 (0·79-1·77) for atrial fibrillation; hence the excess risk differed by up to five times across the diagnosis age groups. The highest overall incidence rate, noted for all-cause mortality, was 1·9 (95% CI 1·71-2·11) per 100 000 person-years for people with type 1 diabetes. Development of type 1 diabetes before 10 years of age resulted in a loss of 17·7 life-years (95% CI 14·5-20·4) for women and 14·2 life-years (12·1-18·2) for men.Interpretation Age at onset of type 1 diabetes is an important determinant of survival, as well as all cardiovascular outcomes, with highest excess risk in women. Greater focus on cardioprotection might be warranted in people with early-onset type 1 diabetes.Funding Swedish Heart and Lung Foundation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(18)31506-x

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: A meta-analysis
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,455
Mortality and cardiovascular disease in type 1 and type 2 diabetes
Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A.-M., Miftaraj, M., McGuire, D. K., Sattar, N., Rosengren, A., & Gudbjörnsdottir, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608664 · Cited by 1,389
Self-citation
Diabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255
Excess Mortality among Persons with Type 2 Diabetes
Tancredi, M., Rosengren, A., Svensson, A., Kosiborod, M., Pivodic, A., Guðbjörnsdóttir, S., Wedel, H., Clements, M. A., Dahlqvist, S., & Lind, M. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504347 · Cited by 1,026
Self-citation
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Self-citation

Show all 40 references

Sorted by citations

Items 501–600 of 801

Mapping care provision for type 1 diabetes throughout Australia: a protocol for a mixed-method study
Carrigan, A., Lake, R., Zoungas, S., Huynh, T., Couper, J., Davis, E. A., Jones, T. W., Bloom, D. E., Braithwaite, J., & Zurynski, Y. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-067209 · Cited by 3
Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trials
Min, T., & Bain, S. C. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2188191 · Cited by 4
“Furthermore, people with T1DM have an increased risk of premature death compared with the general population [16,17].”
Background
Diabetes duration or age at onset and mortality in insulin-dependent diabetics: a systematic review and meta-analysis
Wang, X.-M., Zhong, S., Li, G., & Zhuge, F. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01113-x · Cited by 3
“[11] discovered that patients who developed IDDM between the age of 0 and 10 had hazard ratios for all-cause mortality of 4.”
BackgroundResult
The effect of physical activity on cytokine levels in adults living with type 1 diabetes—a preliminary study
Kowal, M., Woźniacka, R., Ścisłowska‐Czarnecka, A., Homa, J., & Głodzik, W. (2024) · Physiological Reports · doi:10.14814/phy2.15985 · Cited by 2
“Apart from CVD, cancer has become the main cause of premature death among individuals with T1DM (Fellinger et al., 2019; Rawshani et al., 2018).”
Background
Carbohydrate reduction for metabolic disease is distinct from the ketogenic diet for epilepsy
Calkins, M. W., Buchanan, L., Kalayjian, T., Dikeman, D. T., Cucuzzella, M. T., & Westman, E. C. (2024) · Journal of Metabolic Health · doi:10.4102/jmh.v7i1.95 · Cited by 3
Sleep Disturbances in Type 1 Diabetes and Mitigating Cardiovascular Risk
Irsheed, G. A., Martyn-Nemeth, P. A., Baron, K. G., & Reutrakul, S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae539 · Cited by 4
Adolescents with long-duration type 1 diabetes have low bone mass and reduced levels of bone indices reflecting altered bone resorption
Swolin‐Eide, D., Lyckå, A. P., Novák, D., Andersson, B., Forsander, G., & Magnusson, P. (2025) · Bone · doi:10.1016/j.bone.2025.117560 · Cited by 4
Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data Network
Robertson, C. A., Earnest, A., Chee, M., Craig, M. E., Colman, P. G., Barrett, H. L., Bergman, P. B., Cameron, F. J., Davis, E. A., Donaghue, K. C., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14584 · Cited by 3
“Children who develop T1D before the age of 10 years are particularly at risk of cardiovascular disease in adult life.(3) Monitoring of cardiovascular risk factors during childhood and adolescence is recognized as an essential part of care.”
Background
Monitoring of continuous subcutaneous insulin infusion treatment in Portugal and its implications for diabetes management
Figueiredo, A. R., Matos, T., & do Vale, S. (2022) · HORMONES · doi:10.1007/s42000-022-00412-8 · Cited by 3
“The longer the course of the disease and the worse the glycemic control, the greater the risk for complications [3, 4], so that type 1 diabetes, as a disease with a predominant incidence in childhood, in the long term presents a risk for the health of this population.”
Background
Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research’s Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases
Cefalu, W. T., Andersen, D. K., Arreaza-Rubín, G., Pin, C. L., Sato, S. M., Verchere, C. B., Woo, M., Rosenblum, N. D., Rosenblum, N. D., Cefalu, W. T., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.09.126 · Cited by 3
Prevalence of Dyslipidemia and Hypertension in Iraqi Adolescents with Type 1 Diabetes Mellitus
Abdoun, D. S., Al-Rawi, R. A., & Abulmajeed, B. (2022) · Al- Anbar Medical Journal · doi:10.33091/amj.2022.176311 · Cited by 3
“There is an increased risk of 2-11 times of premature cardiovascular problem in patients with T1DM and it is considered one of the most frequent reasons of death in those patients [7, 8].”
Background
Nationale Diabetes Registratie
Serné, E. H., Mourits, P., & van Strien, M. (2020) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-020-0131-2 · Cited by 3
Wenn Menschen mit Typ-1-Diabetes erwachsen werden
Datz, N., Kordonouri, O., & Danne, T. (2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1332-4603 · Cited by 3
“[3] Rawshani A, Sattar N, Franzén S et al.”
Background
Technology in the Changing Management of Diabetes in Children
Bruttomesso, D. (2023) · New England Journal of Medicine · doi:10.1056/nejme2301252 · Cited by 3
Also the parents of children with type 1 diabetes need psychological support
Ludvigsson, J. (2024) · Acta Paediatrica · doi:10.1111/apa.17188 · Cited by 3
Elevated Serum IgA at Onset of Type 1 Diabetes in Children
Thakkar, A., Huang, X., Wang, J. Z., Hwu, K., Chinn, I. K., Minard, C. G., Hajjar, J., & REDONDO, M. J. (2024) · Pediatric Diabetes · doi:10.1155/2024/7284088 · Cited by 2
Long‐term effects of non‐pharmacological interventions in adolescents and young adults with type 1 diabetes: A systematic review and meta‐analysis
Lee, D., Lee, H., Lee, M., & Park, G. (2024) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12751 · Cited by 2
“A cohort study with a 10-year follow-up involving patients with T1D revealed a nine-fold higher incidence of coronary artery disease in patients with T1D compared to the general population (Rawshani et al., 2018).”
Targeting Myostatin as an Adjunct Treatment for the Preservation of Cardiometabolic and Skeletal Muscle Function in Type 1 Diabetes
Nunan, E. L., Huff, D. R., Gore, J. L., Wright, C. L., Harris, T., Butler, L., Padgett, C. A., Rochowski, M. T., Lovern, P. C., Boolani, A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104830 · Cited by 2
Global epidemiology of type 1 diabetes in youth: 1990–2021 and projections to 2045
Zhang, K., Kan, C., Han, F., Ma, Y., Wang, Y., Li, X., Xiong, G., Chen, J., Yu, X. Q., Hou, N., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04356-y · Cited by 3
“Individuals with T1D face a mortality risk 2 – 8 times higher than non-diabetics, reducing life expectancy by about 12 years [5].”
Short-term low-carbohydrate diet decreases body weight and fat mass but not muscle strength in children and young people with type 1 diabetes
Neuman, V., Maratova, K., Plachy, L., Drnková, L., Pruhova, S., Koloušková, S., Obermannová, B., Amaratunga, S., Kulich, M., Havlik, J., et al. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01658-2 · Cited by 2
“Yet, there is still a signi ﬁ cant gap in the life expectancy of people with or without T1D partly caused by high cardiovascular mortality [2].”
Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post‐diagnosis: A cross‐sectional, real‐world observational study
Lavens, A., Block, C. E. M. D., Oriot, P., Philips, J., Vandenbroucke, M., Crenier, L., Nobels, F. R. E., Mathieu, C., & the Belgian Group of Experts IQED (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70049 · Cited by 2
“23,24 25 In addition to improvements in glycaemic control, these previous studies attributed the significant decline in albuminuria to diagnostic tools and enhanced overall metabolic management, including adjustments in blood pressure targets, the availability of Renin-Angiotensin-Aldosterone…”
Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010–2019): A Population-Based Study Using a Machine Learning Classification Algorithm
Fagherazzi, G., Sérusclat, P., Roux, B., Bretin, O., Casarotto, E., Rabiéga, P., Rabat, Y., Berteau, C., Pouyet, A., & Joubert, M. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01781-0 · Cited by 2
A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallest
Biester, T., Reschke, F., Danne, T., Julien, M., Lutsar, I., Cheng, K. Y., Cavaller-Bellaubi, M., Katz, M., Niemöller, E., Renard, É., et al. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2025-0327 · Cited by 2
Consistent efficacy and safety of automated insulin delivery in children aged 2–6 years: results from the LENNY trial continuation phase
Dovč, K., Tuomaala, A., Kuusela, S., Shetty, A., Rabbone, I., Tiberi, V., Campbell, F., Peters, C. J., Ahomäki, R., Zanfardino, A., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112934 · Cited by 2
EndoCompass project: research roadmap for diabetes, obesity, and metabolism
Mathieu, C., Meireles, M., Pagotto, U., Wabitsch, M., Banerjee, I., Bartolomé, A., Battelino, T., Beck, J., Chiarelli, F., León, D. D. D., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf065 · Cited by 4
Characteristics of above 65-year-olds with type 1 diabetes in the Finnish diabetic nephropathy study
Franzén, E. M. C., Eriksson, M. I., Satuli-Autere, S., Ylinen, A., Sigfrids, F. J., Nicklén, J., Öhman, H., Groop, P., Thorn, L. M., & the FinnDiane Study Group (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02613-0 · Cited by 2
“In line with this, individuals with diabetes onset in childhood are at exceptionally high risk of dying early [18, 19].”
Enhancing nationwide awareness of cholesterol treatment in type 1 diabetes ( ENACT ‐ T1D ): an Australian multi‐centre survey of patients and clinicians
Lan, N. S. R., Ryan, C. D., Rudén, A., Glasby, J. R. K., Nanayakkara, N., Elghattis, Y., Brazionis, L., Huang, M., Lum, S., Januszewski, A. S., et al. (2025) · Internal Medicine Journal · doi:10.1111/imj.70276 · Cited by 3
High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes
Lan, N. S. R., Fegan, P. G., & Jenkins, A. J. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109268 · Cited by 2
MiniMed TM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics
Kountouri, A., Ikonomidis, I., Katogiannis, K., Thymis, J., Pavlidis, G., Korakas, E., Pliouta, L., Agapitou, V., Liatis, S., Petrovski, G., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261417289 · Cited by 2
The psychological impact of time in tight range in adolescents with type 1 diabetes: insights from real-life clinical practice
Passanisi, S., Bombaci, B., Longo, A., Alibrandi, A., Salzano, G., & Lombardo, F. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113160 · Cited by 3
High LDL-cholesterol in children and adolescents with type 1 diabetes: the impact of body adiposity and sex
Maffeis, C., Morotti, E., Caiazza, E., Pedranzini, Q., Soglia, A., Kharazizadeh, P., Marigliano, M., & Piona, C. A. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104629 · Cited by 2
Potential years of life lost and factors associated with different causes of death in type 1 diabetes in Finland
Keisala, E., Kauppala, T., Vanhamäki, S., Haapakoski, J., Laatikainen, T., & Metso, S. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109312 · Cited by 2
Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica
Armario, P., Brotons, C., Elosúa, R., de Leciñana, M. A., Castro, A., Clarà, A. B. I., Cortés, O., Rodríguez, Á. D., Herranz, M., Justo, S., et al. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.11.004 · Cited by 2
“La edad en el inicio de la DM1 también es un determinante importante de la supervivencia y de EV (40).”
Caring for Young Adults With Diabetes in the Adult Care Setting: Summary of a Multidisciplinary Roundtable
Toschi, E., Leblanc, J., Hafida, S., Mehta, S. N., Ritholz, M. D., Gabbay, R. A., & Laffel, L. M. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.830183 · Cited by 2
Comparison of anxiety, stress, and social support levels of female patients with type 1 diabetes and mothers whose children have type 1 diabetes
Karaman, İ. G. Y., Altınöz, A. E., Buyruk, B. A., Yorulmaz, G., Köşger, F., & Kırel, B. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01144-7 · Cited by 2
Prevalence of LDL-hypercholesterolemia and other cardiovascular risk factors in young people with type 1 diabetes
Drozd, I., Weiskorn, J., Lange, K., Biester, T., Datz, N., Kapitzke, K., Reschke, F., Berge, T. V. D., Weidemann, J., Danne, T., et al. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.05.097 · Cited by 2
Assessment of selected muscle damage markers and zonulin concentration after maximum-intensity exercise in men with type 1 diabetes treated with a personal insulin pump
Matejko, B., Tota, Ł. M., Morawska-Tota, M., Pałka, T., Malecki, M. T., & Klupa, T. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02157-1 · Cited by 2
“Type 1 diabetes mellitus (T1D) is a chronic progressive disease that results in increased mortality [7].”
Background
Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I
Rajapaksa, R., Davis, W. A., & Davis, T. M. E. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003501 · Cited by 2
Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart
Doğanyiğit, Z., Okan, A., Taheri, S., Şükranlı, Z. Y., Akyüz, E., & Demır, N. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14308 · Cited by 3
Increased Frequency of Giant Miniature End-Plate Potentials at the Neuromuscular Junction in Diabetic Rats
Martínez-Sánchez, J. E., Cárdenas, Y., Trujillo, X., Ríos‐Silva, M., Díaz‐Reval, I., Bricio‐Barrios, J. A., Muñı́z, J., Alcaraz-Siqueiros, J., & Huerta, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010068 · Cited by 2
“It has been predicted that by 2030, the global prevalence of T2DM will increase to 7079 cases per 100,000 individuals, with a continuous increase in each region of the world [1,6].”
Background
Excess Mortality in an Inception Cohort of Childhood Diabetes Diagnosed 1990–2010
Lain, S. J., Stevens, L. M., Craig, M. E., Jenkins, A. J., Bell, K. J., Pryke, A., Donaghue, K. C., & Nassar, N. (2024) · Pediatric Diabetes · doi:10.1155/2024/1844752 · Cited by 2
“Another factor that may be important to investigate in relation to mortality rates of people with type 1 diabetes is age at diagnosis; however, this factor has been less frequently examined and studies have shown con ﬂ icting results [7 – 9].”
Genetic Causality between Type 1 Diabetes and Arrhythmia Identified by a Two-sample Mendelian Randomization Study
Liu, Y., Rao, J., Hu, W., Yu, Y. S., Wang, P., Chen, X., Zhang, Y., & Wang, Z. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111725 · Cited by 2
Rapid Improvement in Weight, Body Composition, and Glucose Variability With Semaglutide in Type 1 Diabetes
Gad, H., & Malik, R. A. (2024) · Cureus · doi:10.7759/cureus.61577 · Cited by 2
“An increasing proportion of adults with T1DM are now overweight or obese, which impacts glycemic variability and overall glycemic control, which may increase the risk of both microvascular and macrovascular complications [7].”
Background
Mortality patterns in Dutch diabetes outpatients
Bak, J. C. G., de Vries, S. A. G., Serné, E. H., Groenwold, R. H. H., de Valk, H. W., Mul, D., Sas, T., Bizino, M. B., Nieuwdorp, M., Kramer, M. H. H., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15750 · Cited by 2
Early increase in carotid intima-media thickness in women with childhood-onset type 1 diabetes compared with healthy peers: the Norwegian Atherosclerosis and Childhood Diabetes study
Simeunovic, A., Brunborg, C., Heier, M., Berg, T. J., Dahl‐Jørgensen, K., & Margeirsdottir, H. D. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004505 · Cited by 2
“5 28 The risk of CVD, regardless of sex, is also increased if there is childhood-onset T1D.”
The Importance of Instigating Automated Insulin Delivery Systems at Onset of Type 1 Diabetes: 1-Year Follow-Up of Children and Adolescents from Two Tertiary Pediatric Diabetes Centers
Rabbone, I., Savastio, S., Castorani, V., Chiarle, E., Ferrari, A., Pozzi, E., Cavalli, C., & Scaramuzza, A. E. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0057 · Cited by 2
Adult-onset type 1 diabetes: new insights but still much to learn
Magliano, D. J., & Rolandsson, O. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf427 · Cited by 2
Mediterranean diet adherence among adolescents with type 1 diabetes: Insights into dietary patterns, glycemic control, and gender differences.
Gillon-Keren, M., Propper-Lewinsohn, T., David, M., Fayman, G., Phillip, M., & Oron, T. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112400 · Cited by 2
Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin
Klugar, M., Klugarová, J., Pokorná, A., Benešová, K., Jarkovský, J., Dolanová, D., Mužı́k, J., Líčeník, R., Prázný, M., Búřilová, P., et al. (2019) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000188 · Cited by 2
“©2019 Un age; these results are consistent with another recently published study.(8) Figure 3 is showing complications of T1DM.”
Result
Cardiac Autonomic Neuropathy Is Not Reversed by Euglycemia Following Islet Transplantation
Deshmukh, T., Emerson, P., Anderson, P., Kizana, E., O’Connell, P. J., Holmes-Walker, D. J., & Chong, J. J. H. (2020) · Transplantation · doi:10.1097/tp.0000000000003377 · Cited by 2
“Diabetes remains a substantial risk factor in the development and progression of cardiovascular disease and continues to be the leading cause of mortality with significant reduction in life span for both men and women with type 1 diabetes (T1D).(1) Cardiac autonomic neuropathy (CAN) is defined as any abnormality in he…”
Background
Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Pietraszek, A. (2020) · Current Drug Safety · doi:10.2174/1574886315666200902154736 · Cited by 2
Early Prediction of Cardiovascular Disease Among Young Adults Through Coronary Artery Calcium Score Technique
Bhatt, A., Dubey, S. K., & Bhatt, A. K. (2021) · Communications in computer and information science · doi:10.1007/978-3-030-88244-0_29 · Cited by 2
Course of screening-based depression in young adults with a long type 1 diabetes duration: Prevalence and transition probabilities – A cohort study
Bächle, C., Stahl‐Pehe, A., Castillo, K., Lange, K., Holl, R. W., & Rosenbauer, J. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109220 · Cited by 2
Diabetes bei Kindern – die richtigen Weichen stellen
Reschke, F., Berge, T. V. D., Galuschka, L., Biester, T., Datz, N., Kapitzke, K., Weiskorn, J., Kordonouri, O., Lange, K., & Danne, T. (2022) · Der Diabetologe · doi:10.1007/s11428-021-00833-w · Cited by 2
“Dem zugrunde liegt ein enger Zusammenhang zwischen den durchschnittlichen Glukosespiegeln und -schwankungen und einer erhöhten kardiovaskulären Morbidität und Mortalität [26].”
Background
Mekanisme Penghambat Sodium-Glukosa Transport Protein-2 (SGLT2-i) pada Penyakit Kardiovaskular: Sebuah Tinjauan
Besmaya, B. M., & Laksono, S. (2023) · MPI (Media Pharmaceutica Indonesiana) · doi:10.24123/mpi.v5i1.5266 · Cited by 3
“Pasien dengan risiko sangat tinggi berisiko mengalami kematian akibat PKV >10% dalam 10 tahun [62].”
Ambulatory Blood Pressure Monitoring as a Useful Tool in the Cardiological Assessment of Pancreas Transplant Recipients with Type 1 Diabetes
Buksińska−Lisik, M., Kwasiborski, P. J., Ryczek, R., Lisik, W., & Mamcarz, A. (2023) · Diagnostics · doi:10.3390/diagnostics13172724 · Cited by 2
Decreasing national trends in diabetic complications hide regional differences: a prospective population-based study using health care registers in Finland
Winell, K., Arffman, M., & Salomaa, V. V. (2023) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2023.2247190 · Cited by 3
“The same detrimental effects have been seen among patients with type 1 diabetes [9].”
Background
General clinical and anthropometric parameters in patients with type 1 diabetes mellitus depending on the level of albumin in the urine
Kryvoviaz, Y. O. (2020) · Biomedical and Biosocial Anthropology · doi:10.31393/bba38-2020-09 · Cited by 2
“Currently, about 380 million people worldwide suffer from diabetes and it is projected that by 2035 this figure will double [8, 15, 16].”
Background
Excess mortality and cardiovascular disease risk in type 1 diabetes – Authors' reply
Rawshani, A., Sattar, N. A., Franzén, S., Rawshani, A., & Guðbjörnsdóttir, S. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33061-7 · Cited by 2
Self-citation
Reflections on Diabetes Care at the End of the Second Decade of the 21st Century
Garg, S. K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0014 · Cited by 2
Endocrine-enriched stem cell-derived islets improve long-term safety in vivoPreprint
Setyono, E. S. A., Rogers, N. K., Scheibner, K., Schirge, S., Reich, H., Sterr, M., Öztürk, T., Franzenburg, S., Lithovius, V., & Lickert, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.22.671768 · Cited by 2
“Life expectancy in children diagnosed before the age of 10 is reduced by 14-18 years, with the highest risk in women 1 .”
Preventive Cardiology
Maleki, M., & Hosseini, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00012-0 · Cited by 1
Clinical Care of Lipids in People with Type 1 Diabetes
Lan, N. S. R., Jenkins, A. J., & Fegan, P. G. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_28 · Cited by 2
Neighbourhood Environments and Lifestyle Behaviours in Adolescents With Type 1 Diabetes
Syragakis, K. M., Henderson, M., Harnois‐Leblanc, S., Barnett, T. A., Mathieu, M.-E., Drapeau, V., Benedetti, A., & Hulst, A. V. (2024) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2024.07.003 · Cited by 1
Are Trends in Economic Modeling of Pediatric Diabetes Mellitus up to Date with the Clinical Practice Guidelines and the Latest Scientific Findings?
Cardona‐Hernandez, R., de la Cuadra-Grande, A., Monje, J., Echave, M., Oyagüez, I., Álvarez, M., & Gea, I. L. (2025) · Journal of health economics and outcomes research · doi:10.36469/jheor.2025.127920 · Cited by 3
Improved self‐management of type 1 diabetes in young women: Experiences of Guided Self‐Determination‐Young: A qualitative interview study
Haas, J., Persson, M., Toft, E., Nirs, J., Lindström, M., Olinder, A. L., & Brorsson, A. L. (2025) · Diabetic Medicine · doi:10.1111/dme.70029 · Cited by 1
Age‐ and sex‐dependent lipid trajectories in children and adolescents with type 1 diabetes—A Danish nationwide registry‐based study
Lund, E. J., Vistisen, D., Svensson, J., Birkebæk, N., & Rønn, P. F. (2025) · Diabetic Medicine · doi:10.1111/dme.70055 · Cited by 1
Effect of glycemic status on myocardial deformation and microvascular function in uncomplicated pediatric type 1 diabetes mellitus: cardiac magnetic resonance imaging
Zhang, L., Huang, S., Li, X., Yang, Z., Ye, P., Sun, R., Xu, H., Xu, R., Zhang, M., Liu, Y., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02757-x · Cited by 2
“Individuals diagnosed with T1DM before age 10 face a sevenfold higher CVD mortality risk compared to those non-diabetic peers [4], suggesting that myocardial changes may begin early in childhood-onset T1DM.”
Clinical and prognostic differences in diabetic ketoacidosis between type 2 and type 1 diabetes
Sanchiz, M. S. T., Navas-Moreno, V., Ruano, M. L., Martínez-Otero, C., Carrillo-López, E., Ganga, C. S. L., López, J. J. R., Amar, S., Castañar, S. G., Martín, J. A. A., et al. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2025.106973 · Cited by 1
Factors of Composite Target of Time in Range and Time Below Range Among Children and Adolescents With Type 1 Diabetes Mellitus Using Open-Source Automated Insulin Delivery
Lei, M., Zhou, Y., Wang, C., Ling, P., Ni, Y., Yang, D., Yang, X., Xu, W., Deng, H., & Yan, J. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.006 · Cited by 1
Low LDL particle levels associate with coronary arteries free from atherosclerosis in long-term type 1 diabetes: the Dialong study
Narum, M., Christensen, J. J., Holven, K. B., Berg, T. J., & Sveen, K. A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02844-z · Cited by 1
“The prevalence of cardiovascular disease is high in patients with type 1 diabetes and an important cause of mortality [4, 5].”
Uric acid and future complications in young individuals with type 1 diabetes: results from the Diabetes Incidence Study in Sweden (DISS) and the National Diabetes Registry of Sweden (NDR)
Fagher, K., Eeg‐Olofsson, K., Arnqvist, H. J., Bolinder, J., Eriksson, J. W., Guðbjörnsdóttir, S., Nyström, L., & Landin‐Olsson, M. (2025) · Diabetologia · doi:10.1007/s00125-025-06561-w · Cited by 1
“Although the majority of CVD occurs in individuals with type 2 diabetes, considering that people with type 1 diabetes are younger at onset, they consequently risk losing more life-years from CVD [3, 4].”
Familial Hypercholesterolemia in Pediatric Patients With Type 1 Diabetes: Double Challenge for Diagnosis and Treatment
Becker, M., Weiskorn, J., Wiegand, S., Röbl, M., Meißner, T., Schulz, E., Golembowski, S., Schwab, K. O., Meraner, D., & Holl, R. W. (2025) · Diabetes Care · doi:10.2337/dc25-1195 · Cited by 1
Type 1 diabetes mellitus and atrial fibrillation: clinical relationships, mechanistic insights, and therapeutic implications
Bruns, F., Fender, A. C., Poppenborg, T., Dudley, S. C., & Dobrev, D. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf252 · Cited by 2
Eligible but Untreated: Gaps in Statin Therapy for Type 1 Diabetes Under the National Institute for Health and Care Excellence (NICE) Guidelines
Riasat, M. H., Nafees, S., Malik, S., Rahman, S., Lopez, K., Abdulhadi, O., Wright, N., Chikhal, R., & Benamer, S. (2025) · Cureus · doi:10.7759/cureus.98557 · Cited by 1
Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes
Prampolini, B., Eryılmaz, C. C., & Marcovecchio, M. L. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/2449658 · Cited by 2
“These ﬁ ndings are particularly concerning because of the increased burden associated with an early onset of Type 1 diabetes and the longer exposure to hyperglycemia and other cardiometabolic risk factors contributing to vascular complications [7].”
(TCRαβ+) Double-Negative T Cells in Type 1 Diabetes Mellitus
Poddighe, D., Mussayeva, A., Dossybayeva, K., Zhubanova, G., Galiyeva, D., Le, K. L., & Tanko, N. M. (2025) · Cells · doi:10.3390/cells15010058 · Cited by 1
Epidemiological trends and demographic disparities in type 1 Diabetes-related mortality in the United States (1999-2020): a CDC WONDER analysis
Khan, S., Najam, F., Shakil, R., Javed, M., Anwar, T., Zafar, S., Bhatti, A. R., Munir, H., Butt, M., Pirzada, M. W., et al. (2026) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2026.100300 · Cited by 1
Beyond BMI: Ultrasound-Detected Visceral Adiposity as a Predictor of Early Cardiometabolic Dysfunction in Youth with Type 1 Diabetes
Özde, Ş., Aktüre, G., Özel, M. A., Yavuzyılmaz, F., Özde, C., Kayapınar, O., & Arslanoğlu, İ. (2026) · Children · doi:10.3390/children13010124 · Cited by 2
“Despite improvements in diagnosis and therapy, mortality remains two-to eightfold higher than in the nondiabetic population, largely due to cardiovascular disease [6,7].”
Geospatial clustering of type 1 diabetes in Sweden: a cohort study based on all residential locations from birth to diagnosis
Sebraoui, S., Englund, O., Nyberg, F., Carlsson, A., Korsgren, O., Forsander, G., Eeg‐Olofsson, K., Eliasson, B., Carlsen, H. K., Åkesson, K., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06675-9 · Cited by 1
Self-citation
A call to action: A consensus statement on knowledge gaps and research priorities on the management of women with early onset type 2 diabetes in the preconception, pregnancy and postnatal periods
White, S., Schoenaker, D. A. J. M., Mackin, S. T., Forde, R., Flynn, A. C., Dyer, E., Heslehurst, N., Lindsay, R. S., & Meek, C. L. (2026) · Diabetic Medicine · doi:10.1111/dme.70252 · Cited by 1
“…conventionally defined as a diagnosis before 40 years and therefore particularly relevant to reproductive health) carries a high risk of diabetes complications, 3–5 premature cardiovascular disease (CVD), 6–8 multimorbidity 9–11 and mortality, 5,12–14 increasing the medical complexity of pregnancy.”
Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction
Serés‐Noriega, T., Lafarga, I. A., Perea, V., Viñals, C., & Amor, A. J. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2642404 · Cited by 2
“This is particularly relevant given that early age at diagnosis has been strongly associated with atherosclerotic CVD (ASCVD) [7], and that atherosclerotic plaque formation may begin in childhood and adolescence, promoted by the cumulative effects of T1D [15,16].”
Clinical Characteristics and Predictors of Glycemic Control During the First 24 Months After Diagnosis of Type 1 Diabetes
Löffler, S., Frigo, F. F., Hochfellner, D. A., Fröhlich-Reiterer, E. E., Aziz, F., Kubesch, H., Pieber, T. R., Sourij, H., & Aberer, F. (2026) · Biomedicines · doi:10.3390/biomedicines14030690 · Cited by 1
“This finding is in strong agreement with large registry and cohort studies demonstrating deterioration of glycemic control during adolescence and young adulthood [13].”
Statin prescription rates for prevention of atherosclerotic cardiovascular disease in adults 40–75 years old with type 1 diabetes
Lundholm, M. D. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112682 · Cited by 1
Managing Obesity in Individuals with Cardiovascular Disease: Are We Missing the Obvious?
Gao, M., Kurala, T. S., & Ajjan, R. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.53 · Cited by 1
“58 While several guidelines, such as the European Society of Cardiology, American Diabetes Association and National Institute for Health and Care Excellence, acknowledge the increased CVD risk in individuals with T1D who are overweight or have obesity, there is a clear absence of tailored…”
Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial
Beernink, J. M., Heerspink, H. J. L., Birkenfeld, A. L., Cherney, D. Z. I., Colhoun, H. M., Groop, P., Ji, L., Mathieu, C., Rosas, S. E., Tuttle, K. R., et al. (2026) · Diabetes Care · doi:10.2337/dc26-0882 · Cited by 1
Multi-omics reveals microbiota, metabolite, and immunological heterogeneity of age-related endotypes in type 1 diabetes
Pan, L., Tan, H., Yue, T., Ding, Y., Gu, Z., Wang, X., Wang, J., Wei, T., Zhang, X., Shi, Y., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02724-2 · Cited by 2
Continuous Glucose Monitoring Initiation Is Associated With Reduced Mortality in Older-Onset Type 1 Diabetes Patients: A Target Trial Emulation Study Within the Veterans Health Administration
Reaven, P. D., Macwan, S. A., McConeghy, K. W., Norman, G. J., Conlin, P. R., Miller, D. R., & Zhou, J. J. (2026) · Diabetes Care · doi:10.2337/dc26-0425 · Cited by 1
Long-term major adverse cardiovascular and cerebrovascular event risk in adult-onset type 1 versus type 2 diabetes: a propensity-matched cohort study
Astavans, A., Baughman, D. J., & Mathioudakis, N. N. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag360 · Cited by 1
Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register‐Based Cohort Study
Jancev, M., Eliasson, B., Biessels, G. J., DeVries, J. H., Serné, E. H., Visseren, F. L. J., Rawshani, A., Rawshani, A., Cukierman‐Yaffe, T., Sattar, N. A., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71123 · Cited by 1
Self-citation
Diabetes and coronary circulation: From pathology to imaging
Henein, M. Y., Vancheri, S., & Vancheri, F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817428-9.00008-5 · Cited by 1
Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit
Amor, A. J., Ortega, E., Giménez, M., Cofán, M., Blanco, J., Pané, A., Boswell, L., Vinagre, I., Esmatjes, E., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.09.001 · Cited by 1
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00010-3 · Cited by 1
Vascular and Myocardial Structure and Function in Adolescents with Type 1 Diabetes: The CARDEA Study
Harnois‐Leblanc, S., McNealis, V., Friedrich, M. G., Bigras, J., Hulst, A. V., Nuyt, A. M., Barnett, T. A., Benedetti, A., Mathieu, M.-E., Drapeau, V., et al. (2023) · Pediatric Diabetes · doi:10.1155/2023/8662038 · Cited by 1
“Cardiovascular disease (CVD) mortality is sevenfold higher in adults with youth-onset type 1 diabetes compared to individuals without diabetes [1].”
Background
Pediatric Type 1 Diabetes: Is Age at Onset a Determining Factor in Advanced Hybrid Closed-Loop Insulin Therapy?
Jurado, A. L., López‐Siguero, J. P., Gómez‐Perea, A., Jiménez, A. B. A., Becerra‐Paz, I., Ceballos, L. T., Ponce, C. C., Hinojosa, J. M. J., Morcillo, S., & Gea, I. L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216951 · Cited by 2
“…for non-cardiovascular mortality, 11.44 (7.95–16.44) for cardiovascular disease, 30.50 (19.98–46.57) for coronary heart disease, 30.95 (17.59–54.45) for acute myocardial infarction, 6.45 (4.04–10.31) for stroke, 12.90 (7.39–22.51) for heart failure and 1.17 (0.62–2.20) for atrial ﬁbrillation [1–3].”
BackgroundInfluential
Mesenchymal stromal cells modulate unfolded protein response and preserve β-cell mass in type 1 diabetes
LIU, S., ZHAO, Y., YU, Y., Ye, D., WANG, Q., WANG, Z., & LUAN, Z. (2024) · Biocell · doi:10.32604/biocell.2024.050493 · Cited by 1
Diferencias clínicas y pronósticas de la cetoacidosis diabética en diabetes tipo 2 comparado con el tipo 1
Sanchiz, M. S. T., Navas-Moreno, V., Ruano, M. L., Martínez-Otero, C., Carrillo-López, E., Ganga, C. S. L., López, J. J. R., Amar, S., Castañar, S. G., Martín, J. A. A., et al. (2025) · Medicina Clínica · doi:10.1016/j.medcli.2025.106973 · Cited by 1
Modulating the immune system to delay the clinical onset of type 1 diabetes
Sugahara, M., Tanaka, T., & Nangaku, M. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.010 · Cited by 2
High Dietary Salt Intake in Pediatric Patients with Type 1 Diabetes Mellitus Not Related to Overweight and Obesity
Zanfardino, A., Zanfardino, A., Marzuillo, P., Sessa, L., Rollato, A. S., Testa, V., Gallo, M., Piscopo, A., Casaburo, F., Curto, S., et al. (2020) · Journal of Integrative Cardiology Open Access · doi:10.31487/j.jicoa.2020.02.12 · Cited by 1
“Type 1 Diabetes Mellitus increases the risk of cardiovascular diseases that are the main cause of morbidity and mortality in patients with diabetes [1, 2].”
Background
Vorschlag für neue Subklassifikationen des Diabetes mellitus
Zaharia, O., & Szendrödi, J. (2020) · Aktuelle Kardiologie · doi:10.1055/a-1214-5618 · Cited by 1
“[13] Rawshani A, Sattar N, Franzen S et al.”
Background

Authors: Rawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A.-M., Eliasson, B., & Gudbjörnsdottir, S.
Affiliations: Sahlgrenska University Hospital (SE)
University of Glasgow (GB)
Region Västra Götaland (SE)
University of Exeter (GB)
University of Gothenburg (SE)
Corresponding author: Rawshani, Araz
Sattar, Naveed
ORCID: Rawshani, Araz
Sattar, Naveed
Franzén, Stefan
Rawshani, Aidin
Hattersley, Andrew T
Svensson, Ann-Marie
Eliasson, Björn
Venue: The Lancet
Publisher: Elsevier BV
Published: 2018-08
Volume: 392
Issue: 10146
Pages: 477-486
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(18)31506-x
PMC: PMC6828554
OpenAlex: W2887373570
Cited by: 802
References: 40
Citations by year: 2026: 81 · 2025: 103 · 2024: 113 · 2023: 108 · 2022: 101 · 2021: 114 · 2020: 105 · 2019: 67 · 2018: 9
FWCI: 58.64
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Open Research Exeter (University of Exeter) (acceptedVersion, cc-by-nc-nd)
PubMed Central (acceptedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
Figshare (submittedVersion)
Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
Funders: Hjärt-Lungfonden
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords: type 1 diabetes, age at diagnosis, excess mortality, cardiovascular disease, cardiovascular mortality, coronary artery disease, heart failure, atrial fibrillation, acute myocardial infarction, stroke, young adults, risk stratification, diabetes duration, non-cardiovascular mortality, Swedish National Diabetes Register, sex differences in mortality
MeSH terms: Adolescent, Adult, Age Factors, Cardiovascular Diseases, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Humans, Infant, Infant, Newborn, Male, Registries, Sweden, Cohort Studies, Proportional Hazards Models, Age of Onset, Diabetes Complications, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks